FAMEGLOW Secures Hang Seng Composite Index Inclusion, Paving Way for Stock Connect Eligibility

Stock News
Aug 21

On August 21, Hang Seng Indexes Company unveiled the results of its quarterly index review covering the period ending June 30, 2026, with FAMEGLOW (03774) earning a spot in the Hang Seng Composite Index. The adjustment to the index will take effect after the market close on Friday, September 4, and will be implemented starting Monday, September 7. Following this, the Shanghai and Shenzhen stock exchanges are expected to correspondingly update the eligible securities list for the Stock Connect program.

The inclusion of FAMEGLOW (03774) in the Hang Seng Composite Index positions it as a likely candidate for the Stock Connect scheme, given that it now satisfies a range of criteria, including those related to market capitalization and liquidity. This development comes on the heels of the company's official transfer from the GEM board to the Main Board of the Hong Kong Stock Exchange on June 30.

In a recent announcement, FAMEGLOW revealed that its indirect wholly-owned subsidiary, Sohadagenso Hong Kong Limited, has formally entered into a technology development agreement with Hongkong Sunseeker Technology Limited (referred to as "Sunseeker"), a provider of enterprise-level AI transformation services. Under this partnership, the two entities will collaborate deeply, leveraging Sunseeker's proprietary AI models to create a dedicated anti-aging mobile application, marking a strategic push into the "AI + anti-aging" digital intelligence sector.

Sunseeker is set to deploy its substantial technical expertise in AI model research and algorithm implementation, while also integrating the underlying technology support and agent platform capabilities from DEEP, a leading Chinese enterprise-grade AI model company. This collaboration aims to develop a customized AI anti-aging management platform for FAMEGLOW, which will consolidate anti-aging and health assessment report analysis, personalized anti-aging solution formulation, and precise product and service recommendations. The platform is designed to cover the full spectrum of AI-driven anti-aging management, including skin condition monitoring, aging assessment, solution matching, and efficacy tracking.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10